Secondary failure of oral hypoglycaemic agents: frequency, possible causes, and management.

Suppr

超能文献

作者信息

Pontiroli A E, Calderara A, Pozza G

机构信息

Istituto Scientifico San Raffaele, Università degli Studi di Milano, Italy.

出版信息

Diabetes Metab Rev. 1994 Apr;10(1):31-43. doi: 10.1002/dmr.5610100104.

DOI:10.1002/dmr.5610100104

PMID:7956674

Abstract

摘要

相似文献

Secondary failure of oral hypoglycaemic agents: frequency, possible causes, and management.

Diabetes Metab Rev. 1994 Apr;10(1):31-43. doi: 10.1002/dmr.5610100104.

New pharmacologic approaches to the treatment of diabetes.

Spec Top Endocrinol Metab. 1984;6:163-92.

Insulin responses to sulfonylureas.胰岛素对磺脲类药物的反应。

Diabetes Res Clin Pract. 2002 Apr;56(1):69-70; author reply 71. doi: 10.1016/s0168-8227(01)00356-4.

[Insulin monotherapy in patients with diabetes mellitus type 2 developing secondary resistance to sulfanilamide preparations].

Lik Sprava. 2000 Mar(2):72-4.

[Pathophysiology of diabetes mellitus type 2 and the mechanism of action and indications for using hypoglycemic sulfonylurea derivatives].

Pol Tyg Lek. 1985 May 6;40(18):505-11.

[Secondary sulfonylurea failure].[继发性磺脲类药物失效]

Dtsch Med Wochenschr. 1990 Sep 14;115(37):1404-7. doi: 10.1055/s-2008-1065172.

Symposium on diabetes mellitus and oral hypoglycaemic drugs. Summary.糖尿病与口服降糖药研讨会。总结。

Aust N Z J Med. 1971 Aug;1:Suppl 2:83-5.

The combined treatment with insulin and sulfonylurea in non-insulin-dependent diabetic patients with secondary failure. Rationale and guidelines.

Diabetes Res Clin Pract. 1988;4 Suppl 1:75-81. doi: 10.1016/0168-8227(88)90019-8.

Hypoglycaemic and anti-hyperglycaemic drugs for the control of diabetes.

Proc Nutr Soc. 1991 Dec;50(3):619-30. doi: 10.1079/pns19910075.

Weight loss reverses secondary failure of oral hypoglycaemic agents in obese non-insulin-dependent diabetic patients independently of the duration of the disease.体重减轻可逆转肥胖非胰岛素依赖型糖尿病患者口服降糖药的继发性失效，且与病程长短无关。

Diabete Metab. 1993 Jan-Feb;19(1):30-5.

引用本文的文献

Venom Peptides, Polyphenols and Alkaloids: Are They the Next Antidiabetics That Will Preserve β-Cell Mass and Function in Type 2 Diabetes?毒液肽、多酚和生物碱：它们会是下一批可在 2 型糖尿病中保护β细胞质量和功能的抗糖尿病药物吗？

Cells. 2023 Mar 20;12(6):940. doi: 10.3390/cells12060940.

Beta-cell function in type 2 diabetic patients who failed to maintain good glycemic status with a combination of maximum dosages of metformin and sulfonylurea.在使用最大剂量二甲双胍和磺脲类药物联合治疗仍未能维持良好血糖状态的2型糖尿病患者中的β细胞功能。

Diabetes Metab Syndr Obes. 2019 May 21;12:761-770. doi: 10.2147/DMSO.S204439. eCollection 2019.

Plants used in the management of diabetic complications.用于治疗糖尿病并发症的植物。

Indian J Pharm Sci. 2014 Mar;76(2):97-106.

DURATION-1: exenatide once weekly produces sustained glycemic control and weight loss over 52 weeks.度拉糖肽每周一次治疗可在 52 周内持续控制血糖和减轻体重。

Diabetes Care. 2010 Jun;33(6):1255-61. doi: 10.2337/dc09-1914. Epub 2010 Mar 9.

Applying the Taguchi design for optimized formulation of sustained release gliclazide chitosan beads: an in vitro/in vivo study.应用田口设计法优化格列齐特壳聚糖缓释微丸的处方：一项体内外研究。

AAPS PharmSciTech. 2009;10(1):158-65. doi: 10.1208/s12249-009-9191-8. Epub 2009 Feb 10.

Chronic antidiabetic sulfonylureas in vivo: reversible effects on mouse pancreatic beta-cells.慢性抗糖尿病磺脲类药物在体内：对小鼠胰腺β细胞的可逆作用。

PLoS Med. 2008 Oct 28;5(10):e206. doi: 10.1371/journal.pmed.0050206.

The role of sulphonylureas in the management of type 2 diabetes mellitus.磺脲类药物在2型糖尿病管理中的作用。

Drugs. 2004;64(12):1339-58. doi: 10.2165/00003495-200464120-00006.

Induced desensitization of the insulinotropic effects of antidiabetic drugs, BTS 67 582 and tolbutamide.抗糖尿病药物BTS 67 582和甲苯磺丁脲促胰岛素分泌作用的诱导脱敏

Br J Pharmacol. 2000 May;130(2):478-84. doi: 10.1038/sj.bjp.0703306.

Alterations of insulin secretion from mouse islets treated with sulphonylureas: perturbations of Ca2+ regulation prevail over changes in insulin content.磺脲类药物处理的小鼠胰岛胰岛素分泌的改变：Ca2+调节的扰动比胰岛素含量的变化更显著。

Br J Pharmacol. 1999 Aug;127(8):1883-91. doi: 10.1038/sj.bjp.0702731.

Efficacy of combined treatments in NIDDM patients with secondary failure to sulphonylureas. Is it predictable?联合治疗对磺脲类药物继发失效的非胰岛素依赖型糖尿病患者的疗效。是否可预测？

J Endocrinol Invest. 1998 Dec;21(11):744-7. doi: 10.1007/BF03348039.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验